1 An mHealth Framework to Improve Birth Outcomes in Benue State, Nigeria: A Study Protocol

2 A Patient-Held Smartcard With a Unique Identifier and an mHealth Platform to Improve the Availability of Prenatal Test Results in Rural Nigeria: Demonstration Study

3 avaliação de cultivares de bananeira (musa sp) na região de selvíria-ms evaluation of banana (musa sp) cultivars in selvíria-ms region

4 cd8αα expression marks terminally differentiated human cd8+ t cells expanded in chronic viral infection

5 relationship between hbv dna and hbeag in serum and hbcag and inflammation grade in liver tissue among patients with chronic hepatitis b

6 anticuerpos anticitomegalovirus y anti-virus de epstein barr pretrasplante renal en cuba

7 seropositivity of hepatitis b and c among syrian multitransfused patients with hemoglobinopathy

8 conhecimento dos obstetras sobre a transmissão vertical da hepatite b knowledge of obstetricians about the vertical transmission of hepatitis b virus

9 risk factors and seroprevalence of hepatitis b, c, and d virus in hemodialysis patients in istanbul

10 prevalÊncia de doadores com marcadores da hepatite b detectados pela triagem sorolÓgica no instituto onco-hematolÓgico de anÁpolis em 2012 e 2013

11 research advances in drug resistance to nucleos(t)ide analogues in treatment of chronic hepatitis b

12 development of hen antihepatitis b antigen igy-based conjugate for elisa assay

13 effects of nucleos(t)ide analogues on estimated glomerular filtration rate and serum creatinine level in patients with chronic hepatitis b

14 factors associated with failure of clinical screening among blood donors who have altered serological results in the centro regional de hemoterapia de ribeirão preto

15 hbv genotype distribution and its relationship with serum hbv dna level and hbeag expression among patients with chronic hepatitis b in southern zhejiang province, china

16 cyclic thrombocytopenia: a case report

17 hepatitis b virus genotype e detected in brazil in an african patient who is a frequent traveler

18 aplicação do modelo de crenças em saúde na prevenção dos acidentes com agulha application of the health belief model to the prevention of occupational needlestick injuries

19 seropositivity and risk factors of hepatitis b in maharashtra, india

20 evaluating the immunity against hepatitis b virus among yasuj university of medical sciences students-2014

21 assessment of different promoters (camv35s, e8, 2a11) in transient expression of hepaptitis b surface antigene (hbsag) in tomato plant

22 prevalence of antibodies to hepatitis b core antigen in blood donors in the middle west region of brazil

23 research progress in metabolic activity of natural killer cells in patients with chronic hepatitis b virus infection

24 frecuencia de hepatitis b y c en adultos con hemopatías malignas frequency of hepatitis b and c in adults with malignant hemopathies

25 count of peripheral blood dendritic cells and its clinical significance in patients with acute-on-chronic hepatitis b liver failure

26 an epidemiological serosurvey of hepatitis b virus shows evidence of declining prevalence due to hepatitis b vaccination in central china

27 seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, brazil soroprevalência e fatores associados à infecção pelo vírus da hepatite b em população encarcerada no estado do mato grosso do sul, brasil

28 hepatitis b and skin: review

29 clinical trial of telbivudine in the treatment of chronic hepatitis b in patients during the third trimester of pregnancy

30 accidents with biological material and immunization against hepatitis b among students from the health area accidente con material biológico y la vacunación contra la hepatitis b en estudiantes del área de la salud acidente com material biológico e vacinação contra hepatite b entre graduandos da área da saúde

31 clinical and epidemiological aspects of hepatitis b virus and hepatitis c virus in fortaleza-ceara

32 seroprevalence of chronic hepatitis b, as determined from dried blood spots, among children and their mothers in central lao people's democratic republic: a multistage, stratified cluster sampling survey

33 diagnóstico in vivo da asma brônquica

34 Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load.

35 Gold nanoparticles and hepatitis B virus

36 Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

37 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

38 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

39 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

40 Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

41 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

42 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

43 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

44 Safety and efficacy of entecavir for the treatment of chronic hepatitis B

45 New approaches in the management of chronic hepatitis B: role of tenofovir

46 Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

47 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

48 In Silico Screening of Aptamers Configuration against Hepatitis B Surface Antigen

49 Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia

50 Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

51 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

52 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

53 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

54 Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

55 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

56 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

57 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

58 Safety and efficacy of entecavir for the treatment of chronic hepatitis B

59 New approaches in the management of chronic hepatitis B: role of tenofovir

60 Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

61 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

62 Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.

63 Clinical factors leading to a change in management in chronic hepatitis B patients managed in a tertiary setting.

64 What is the optimal timing of antiviral treatment in pregnant hepatitis B carrier with extremely high viral load?

65 High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation

66 Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: An open-label, randomized, controlled study

67 Hepatitis B virus infection: Epidemiology and seroprevalence rate amongst Negrito tribe in Malaysia.

68 Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.

69 The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area.

70 Prevalence of chronic liver disease among young/middle-aged adults in Northern Italy: role of hepatitis B and hepatitis C virus infection by age, sex, ethnicity.

71 Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection

72 Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: A STROBE-compliant national survey-based cross-sectional observational study.

73 Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia

74 Title: p38 mitogen-activated protein kinase impairment of innate immune cells is a characteristic feature of HBeAg-negative chronic hepatitis B.

75 Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk.

76 Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

77 Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches.

78 Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.

79 Assessing the knowledge of expectant mothers on mother–to-child transmission of viral hepatitis B in Upper West region of Ghana

80 LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling

81 Effect of a media intervention on hepatitis B screening among Vietnamese Americans.

82 Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.

83 Correlation of CpG methylation of Pdcd1 gene with PD-1 expression on CD8 T cells and medical laboratory indicators in chronic hepatitis B infection.

84 Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study.

85 Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.

86 Surveillance and impact of occult hepatitis B virus, SEN virus, and Torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection.

87 Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

88 Evaluation of the /S Gene Overlapping Mutations in Chronic Hepatitis B Patients in Northern Cyprus.

89 Dose-dependent pharmacokinetics and tentative identification of urine metabolites from an isosteviol derivative with anti-hepatitis B activity in rats

90 Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon

91 Hepatitis B vaccine knowledge and uptake among medical students in Cameroon

92 Comparing the Effects of Different Story Types and Speakers in Hepatitis B Storytelling Videos.

93 Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species.

94 An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect.

95 Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.

96 The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients

97 Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

98 Preliminary report of the use on adults of a recombinant yeast-derived hepatitis B vaccine manufactured by Instituto Butantan

99 Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.

100 Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection

101 One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor

Keyword Connections

Journals

Research Groups

Bibliographies